Journal of Medicinal ChemistryCancer BiologyPeer-reviewed journal article
ViVo: A temporal modeling framework that boosts statistical power and minimizes animal usage
Guillermo Canudo‐BarrerasiD, Eduardo RomanosiD, Raquel P. HerreraiD, M. Concepción GimenoiD
Abstract
Preclinical tumor studies are often limited by high variability and small sample sizes, reducing statistical power and masking treatment effects. We present an exponential framework that estimates tumor growth rates (r) independently of initial burden and introduces Tumor Growth Rate (TGR) matrices to map treatment effects across time windows. Applied to a public xenograft dataset and four additional mouse models, exponential fits achieved high agreement with raw data (median R2 typically > 0.8-0.9). When resampling matched group sizes (n=3-7), our approach consistently outperformed conventional endpoint and daily non-parametric analyses, revealing treatment effects that standard comparisons missed. The framework also predicts tumor weights for animals euthanized early, enabling their inclusion in final analyses and enhancing statistical consistency while advancing the 3Rs principles. To ensure broad adoption, we developed ViVo, and open-source web platform (gcanudo-barreras.github.io/ViVo-Platform/) that provides accessible, standardized analysis of in vivo tumor kinetics and therapeutic efficacy.
- Citations
- 2
- FWCI
- 1.44
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mathematical models of tumor volume dynamics in response to radiotherapy
N. Mohsin, H. U. Enderling, … M. U. Zahid·bioRxiv·Apr 7, 2022
- Cancer Interception During Treatment: Using Growth Kinetics to Create a Continuous Variable for Assessing Disease Response
Mengxi Zhou, Antonio Tito Fojo, … Krastan B. Blagoev·The OncologistPeer-reviewed·Oct 18, 2025
- Analysis of patient derived xenograft studies in Oncology drug development: impact on design and interpretation of future studies
J. Dickinson, M. de Matas, … H. Mistry·bioRxiv·Mar 15, 2019
- In silico mouse study identifies tumor growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
Qianhui Wu, Alyssa D. Arnheim, Stacey D. Finley·Journal of The Royal Society InterfacePeer-reviewed·Aug 1, 2018
- A reduced Gompertz model for predicting tumor age using a population approach
C. Vaghi, A. Rodallec, … S. Benzekry·bioRxiv·Jun 25, 2019
- A cautionary tale on using tumour growth rate to predict survival
Hitesh B. Mistry·bioRxiv·Oct 11, 2017